Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for Collegium Pharmaceutical (COLL) over the last 6 years, with Q3 2025 value amounting to 0.36%.

  • Collegium Pharmaceutical's Return on Invested Capital fell 300.0% to 0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.22% for FY2024, which is 400.0% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Return on Invested Capital stood at 0.36% for Q3 2025, which was down 300.0% from 0.3% recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Return on Invested Capital peaked at 0.47% during Q2 2021, and registered a low of 1.01% during Q4 2021.
  • Its 5-year average for Return on Invested Capital is 0.17%, with a median of 0.29% in 2023.
  • Per our database at Business Quant, Collegium Pharmaceutical's Return on Invested Capital plummeted by -11600bps in 2021 and then surged by 10400bps in 2022.
  • Over the past 5 years, Collegium Pharmaceutical's Return on Invested Capital (Quarter) stood at 1.01% in 2021, then soared by 104bps to 0.04% in 2022, then surged by 677bps to 0.29% in 2023, then skyrocketed by 41bps to 0.4% in 2024, then decreased by -11bps to 0.36% in 2025.
  • Its last three reported values are 0.36% in Q3 2025, 0.3% for Q2 2025, and 0.32% during Q1 2025.